XPO1 is a new target of homoharringtonine (HHT): Making NPMc<sup>+</sup> AML cells much more sensitive to HHT treatment.
第一作者:
Jingjing,Xue
第一单位:
Liaoning Key Laboratory of Hematopoietic Stem Cell Transplantation and Translational Medicine, Second Hospital of Dalian Medical University, Dalian, China; Department of Hematology, Liaoning Medical Center for Hematopoietic Stem Cell Transplantation, Second Hospital of Dalian Medical University, Dalian, China.
作者:
主题词
人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);核蛋白质类(Nuclear Proteins);细胞核(Cell Nucleus);细胞质(Cytoplasm);突变(Mutation)
DOI
10.1016/j.bbrc.2023.07.027
PMID
37473530
发布时间
2023-08-22
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文